Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Quest Diagnostics (DGX) and Thermo Fisher (TMO)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cigna (CI – Research Report), Quest Diagnostics (DGX – ...
Thermo Fisher sees robust 2025 profit on improved demand for its tools and services
Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.
Thermo Fisher’s Strong Growth Outlook: A Buy Rating with Robust EPS and Margin Expansion
Jefferies analyst Tycho Peterson has reiterated their bullish stance on TMO stock, giving a Buy rating today.Invest with Confidence: Follow ...
Hosted on MSN3d
Thermo Fisher’s (NYSE:TMO) Q4 Sales Beat Estimates
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion.
Hosted on MSN1mon
Jim Cramer on Thermo Fisher Scientific Inc. (TMO): ‘I Think Things Will Gradually Improve For Thermo Fisher With Business Picking Up In 2025 and 2026’
Now some of this was due to tougher comparisons as Thermo Fisher did great business in 2020 and 2021 as drug companies spent fortunes trying to figure out how to fight Covid. Afterwards ...
ncbiotech.org5mon
Thermo Fisher Scientific’s PPD Business Awarded Cancer-Support Contract
PPD, the Wilmington-based clinical research business of Thermo Fisher Scientific, has been awarded a 10-year ... into clinical trials supported by the NCI’s Cancer Trials Support Unit. “NCI’s focus on ...
Business Wire19d
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo Fisher Scientific ...